Changes to challenged stem cell patents are not a step-back from their claims, says WARF

Accidents at university labs working with pathogens suggest an imperfect safety system

The Icelandic research firm reaches a compromise in suit alleging former employees stole trade secrets when they left for academia

Public health expert was fired after complaining about lab cutbacks, judge denies her whistleblower protection

Connecticut's attorney general probes whether the professional society?s Lyme disease guidelines violate antitrust laws

Judge's decision to send gene therapy pioneer French Anderson to prison for 14 years is a "great loss for science"

Lawsuit argues researcher is owed royalties on a blood test based on work cloning human tissue factor

Hakonarson testifies deCODE loses partnerships because Stefansson won't share corporate information

CEO Kari Stefansson testifies against employees who left to work for a new genomics program at The Children's Hospital of Philadelphia

Last December, as the flu season approached, Wyeth Pharmaceuticals' influenza vaccine plant in rural Lancaster County, Pa., stood abandoned.

Before 2001, the company now known as Biovitrum was a group of workers with roots in Pharmacia Corp.'s Swedish research division, which was deemed redundant after Pharmacia merged with Upjohn in 1995.

Medarex, a Princeton, NJ, biotech focused on monoclonal antibodies, has done dozens of straight licensing deals in the past, including an agreement signed last year with Pfizer to produce 50 antibody products over 10 years.